These final results, together with a former report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,two aid the principle of focusing on ACKR3 as a unique strategy to modulate the opioid process, which could open up new therapeutic avenues for opioid-related disorders. Conolidine CONOCB2™ in https://michaeli247suo8.wikicommunications.com/user